|
NAUT Nautilus Biotechnology Inc 1808805 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-14,697,000.00 |
| Balance Sheet |
|
Current Assets
|
$98,832,000.00 |
|
Assets
|
$177,779,000.00 |
|
Current Liabilities
|
$8,343,000.00 |
|
Liabilities
|
$33,364,000.00 |
|
Equity
|
$144,415,000.00 |
|
Shares Out
|
127070480.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-13,100,000.00 |
|
Investing Cash Flow
|
$14,233,000.00 |
| Market Analysis |
Market Cap
|
$130,882,594.40 |
|
Price
|
$0.97 |
|
BVPS
|
1.14 |
|
PB
|
0.90 |
|
EPS
|
-0.12 |
|
FCF
|
$-13,610,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:33 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:30 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
-0.11 |
|
| Apr |
May |
Jun |
|
|
2026-04-28 |
-0.12 |
|
|
|
| Jul |
Aug |
Sep |
|
|
2025-07-31 |
-0.12 |
|
|
|
| Oct |
Nov |
Dec |
|
|
2025-10-28 |
-0.11 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NAUT documents filed with the SEC.
NAUT Filings
Clear
